This paper broadly addresses the overall oncology landscape, providing a forward look at expected developments in a range of tumor types, targets and modalities. It briefly recaps the major developments of 2020, then explores 2021-2022.
Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
